News Tagged ‘Dennis Quaid

FDA announces labeling changes for heparin

The Food and Drug Administration () announced this week safety labeling changes on the heparin to include warnings of fatal medication errors that have resulted in heparin-induced thrombocytopenia (HIT) and -induced thrombocytopenia and thrombosis (HITT), in particular in neonates, or infants less than a year old.

Read the rest of this entry »

Quaid-Cedars-Siani lawsuit over heparin overdose finally closed

Actor Dennis Quaid and his wife Kimberly now have closure in their year-long heparin overdose lawsuit against Cedars-Siani Medical Center, according to OK! and Entertainment Tonight. The entertainment media reported that a Los Angeles judge has signed off on the $750,000 settlement the couple reached with Cedars-Siani last month. According to the settlement, the hospital did not admit wrongdoing in the potentially fatal overdose of heparin that was accidentally administered to the couple’s newborn children Zoe Grace and Thomas Boone Quaid. The settle also allows for the couple to pursue claims for their children in the future. The California Department of Public Heath fined Cedars-Siani $25,000 for the error.

Read the rest of this entry »

Quaids get settlement in heparin overdose case

The highly publicized lawsuit between the family of actor Dennis Quaid and Cedars-Sinai Medical Center has been settled, according to The Lowell Sun/Associated Press. Documents show that the Quaids have agreed on a $750,000 settlement with the hospital. The Quaid twins nearly died after they were accidentally given 1,000 times the intended dose of the heparin shortly after birth. The settlement allows the couple to pursue claims for their children in the future.

Read the rest of this entry »

Drug company launches Web site to highlight safety measures

The sole provider of heparin in the United States, APP Pharmaceuticals LLC, has launched a Web site as a first step toward improving the safety of the medications it sells in the U.S., according to Reuters.

The Web site details the safety measures the pharmaceutical company has taken over the past several months, including enhanced labeling, unit-of-use bar codes, large lettering and color-coded bottle stoppers to help eliminate misuse of its products, which also includes injectible drugs for oncology.

Read the rest of this entry »